Sep 17, 2025 | H&P News, M&A
Basel / Berlin / Rostock, September 2025 – Hoffmann & Partner is pleased to announce that it has advised the shareholders of Nostos Genomics GmbH (“Nostos”) as M&A advisors in the successful acquisition by Limbus Medical Technologies GmbH (“Limbus”). Two...
Sep 3, 2025 | H&P News, M&A
For many entrepreneurs, selling their own company is the crowning glory of a lifetime of business – but also one of the biggest challenges.Successful business succession does not begin with the search for a successor or buyer, but with forward-looking preparation....
Sep 2, 2025 | CFO-Services, Corporate Finance, H&P News
Are you planning to launch medicinal products in Europe? The Luminance Health webinar is designed to equip life science professionals with the insights and tools needed for a successful European launch. Discover how combining expertise in regulatory affairs, quality...
Aug 29, 2025 | Corporate Finance, H&P News, M&A
MaserGrup has made a strategic investment in Holle baby food, a Swiss pioneer in organic and biodynamic infant nutrition, as part of its international expansion into high-value, sustainable food categories. Holle baby food AG, founded in 1934 in Arlesheim...
Aug 12, 2025 | Corporate Finance, H&P News, M&A
Buy-side transactions are not a game of chance. They are based on analysis.In acquisition processes, investment decisions often have to be made under time pressure – with simultaneous information asymmetry between seller and buyer. Those who fail to ask the right...
Jul 24, 2025 | H&P News, M&A
This newsletter provides a comprehensive overview of M&A activity in the healthcare industry across the DACH region, with a particular focus on Switzerland. The analysis covers transactions from 2021 to 2024. At a glance: After a multi-year decline, healthcare...
